Form 4: DENTSPLY SIRONA Director Daniel Scavilla Increases Stake Through Equity Grant
Insider Transaction Report
DENTSPLY SIRONA Inc. Director Daniel T. Scavilla acquired 210.049 shares of common stock, increasing his beneficial ownership.
Summary
- Daniel T. Scavilla, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 210.049 shares of common stock.
- The transaction occurred on July 11, 2025, with a reported price of $0 per share, indicating an equity grant or award.
- Following this acquisition, Daniel T. Scavilla's direct beneficial ownership in DENTSPLY SIRONA Inc. increased to 17,475.049 shares of common stock.
- The Form 4 filing was signed on July 15, 2025, by Jessica Causey, acting as Attorney-in-Fact for Daniel T. Scavilla, under a Limited Power of Attorney executed on May 22, 2025.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive as a director increasing their stake, even through a grant, generally aligns their interests with shareholders. This is a routine compensation event, not indicative of significant operational changes.
Positives
- The acquisition of additional shares by a director, even if through an equity grant, increases their personal stake in the company, aligning their interests more closely with those of shareholders.
- The transaction reflects a standard practice of executive compensation, which can be a positive sign of a structured and competitive compensation framework.
Industry Context
This specific insider transaction is a routine disclosure related to an individual's holdings and does not directly reflect broader industry trends or competitive dynamics. It is common for directors and executives in the dental technology and healthcare industry to receive equity as part of their compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Procedural Authorization | A Limited Power of Attorney was executed by Daniel T. Scavilla, authorizing Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Forms 3, 4, and 5 on his behalf, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934. | 05/22/2025 | This authorization streamlines the process for timely and accurate SEC filings for insider transactions, enhancing compliance efficiency for the reporting person and the company. |
Related Party Transactions
- The acquisition of 210.049 shares of common stock by Daniel T. Scavilla, a Director of DENTSPLY SIRONA Inc., is a related party transaction, likely an equity grant as part of his compensation.
Stakeholder Impact
- Shareholders: The increased beneficial ownership by a director can be viewed positively as it further aligns management's interests with shareholder value creation.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Date Daniel T. Scavilla executed the Limited Power of Attorney authorizing specific individuals to file Section 16 reports on his behalf. |
| 07/11/2025 | Date of the common stock acquisition transaction by Daniel T. Scavilla. |
| 07/15/2025 | Date the Form 4 was signed by the Attorney-in-Fact for Daniel T. Scavilla. |
Keywords
DENTSPLY SIRONA, XRAY, Daniel T. Scavilla, SEC Form 4, Insider Transaction, Common Stock, Director, Beneficial Ownership, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.